Perrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA...

|About: Perrigo Company (PRGO)|By:, SA News Editor

Perrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA for its Androgel testosterone gel, which currently generates $900M in annual worldwide sales. However, Perrigo adds that Abbott (ABT) has filed a patent infringement suit against it over the product.